Publications
Papers
13 peer-reviewed articles and reviews, plus 1 preprint. Full, always-current lists are on ORCID, Google Scholar and PubMed.
2026
- An ancestral tRNA maturation enzyme repurposed for cytoplasmic non-coding RNA processing
bioRxiv (2026)First authorPreprint · not yet peer-revieweddoi:10.64898/2026.10.07.757187
Human ELAC1 (RNase ZS) is dispensable for canonical tRNA processing but binds structured RNA polymerase III transcripts and directly cleaves all four vault RNAs near their 3′ ends — evidence that the two human RNase Z paralogs have specialised. - PNLDC1 deadenylase affects translational rate and cell proliferation in mESCs
RNA (2026) advance online publicationdoi:10.1261/rna.081162.126
Pnldc1-knockout mouse embryonic stem cells stay pluripotent but translate less; the gene is silenced by promoter methylation during differentiation, and two compounds found by virtual screening against a PNLDC1 model curb aberrant proliferation. - Mitochondrial tRNA biogenesis, modifications and disease relevance
Nat Rev Mol Cell Biol (2026) advance online publicationReviewdoi:10.1038/s41580-026-00999-5
Reviews how mitochondrial tRNAs are processed, modified and recognised by co-evolved synthetases and mitoribosomes, and links to human disease and emerging therapies.
2025
- Conduits, Doppelgängers, and Chimeras: RNA Structures at the Virus–Host Interface
Annu Rev Virol (2025) 12(1):277–298First authorReviewdoi:10.1146/annurev-virology-100422-031237
Reviews how structured viral RNAs subvert host machinery — often by mimicking cellular RNAs (“doppelgängers”) or fusing features of several host RNAs (“chimeras”). - Vault Particles in Cancer Progression, Multidrug Resistance, and Drug Delivery: Current Insights and Future Applications
Int J Mol Sci (2025) 26(4):1562Reviewdoi:10.3390/ijms26041562
How vault particles and vault RNAs contribute to cancer progression and multidrug resistance, and their promise as drug-delivery vehicles.
2024
- Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach
Mol Oncol (2024) 19(7):2038–2055doi:10.1002/1878-0261.13765
In 100 SCLC patients, JUNB, CXCR4 and PD-L1 in circulating tumour cells and exosomes emerged as prognostic markers; JUNB/CXCR4-positive CTCs predicted poorer survival. - Recombinant Human TSH Fails to Induce the Proliferation and Migration of Papillary Thyroid Carcinoma Cell Lines
Cancers (2024) 16(14):2604doi:10.3390/cancers16142604
Clinically relevant rhTSH doses did not drive growth or migration of papillary thyroid cancer cells, questioning the rationale for aggressive TSH suppression.
2023
- Integrated signaling and transcriptome analysis reveals Src-family kinase individualities and novel pathways controlled by their constitutive activity
Front Immunol (2023) 14:1224520doi:10.3389/fimmu.2023.1224520
Lck and Lyn act on overlapping substrates but are regulated differently; on their own they trigger activation-like gene expression and ER-phagy in B cells.
2022
- LRF Promotes Indirectly Advantageous Chromatin Conformation via BGLT3-lncRNA Expression and Switch from Fetal to Adult Hemoglobin
Int J Mol Sci (2022) 23(13):7025doi:10.3390/ijms23137025
The transcription factor LRF drives BGLT3 lncRNA expression, opening chromatin to support the switch from fetal to adult haemoglobin.
2021
- The Dynamic Network of RNP RNase P Subunits
Int J Mol Sci (2021) 22(19):10307First authorReviewdoi:10.3390/ijms221910307
A review of RNase P protein subunits — the ribonucleoprotein that matures tRNA 5′ ends — and their emerging moonlighting roles in human cells. - Mitochondrial tRNA-Derived Fragments and Their Contribution to Gene Expression Regulation
Front Physiol (2021) 12:729452First authorReviewdoi:10.3389/fphys.2021.729452
How fragments cleaved from mitochondrial tRNAs under stress, mutation or infection may act as regulators of gene expression.
2020
- Functional and Structural Aspects of La Protein Overexpression in Lung Cancer
J Mol Biol (2020) 432(24):166712doi:10.1016/j.jmb.2020.11.011
La overexpression in lung cancer cells boosts growth and motility and shifts translation toward IRES-driven initiation; NMR shows the La motif alone binds pre-tRNA.
2017
- Expanding the repertoire of deadenylases
RNA Biology (2017) 14(10):1320–1325doi:10.1080/15476286.2017.1300222
Perspective on newly identified deadenylases such as PNLDC1 and their roles in piRNA biogenesis, stem-cell gene regulation and epigenetics.
2016
- Mammalian PNLDC1 is a novel poly(A) specific exonuclease with discrete expression during early development
Nucleic Acids Research (2016) 44(18):8908–8920doi:10.1093/nar/gkw709
PNLDC1 is a new poly(A)-specific exonuclease expressed in embryonic stem cells, testes and early embryos, silenced by DNMT3B methylation.